Optical small animal imaging in the drug discovery process.

Molecular imaging of tumors in preclinical models is of the utmost importance for developing innovative cancer treatments. This field is moving extremely rapidly, with recent advances in optical imaging technologies and sophisticated molecular probes for in vivo imaging. The aim of this review is to provide a succinct overview of the imaging modalities available for rodents and with focus on describing optical probes for cancer imaging.

Domains

Cancer

Fichier principal

review-Correct_hide_JL.pdf (394.91 Ko)

Origin : Files produced by the author(s)

Amandine Hurbin : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00559533

Submitted on : Thursday, January 27, 2011-9:33:59 AM

Last modification on : Thursday, October 13, 2022-3:06:38 PM

Long-term archiving on: Thursday, April 28, 2011-2:36:17 AM

Dates and versions

inserm-00559533 , version 1 (27-01-2011)

Identifiers

HAL Id : inserm-00559533 , version 1
DOI : 10.1016/j.bbamem.2010.03.016
PUBMED : 20346346

Cite

Sandrine Dufort, Lucie Sancey, Christian Wenk, Véronique Josserand, Jean-Luc Coll. Optical small animal imaging in the drug discovery process.. Biochimica et Biophysica Acta - Molecular Cell Research, 2010, 1798 (12), pp.2266-73. ⟨10.1016/j.bbamem.2010.03.016⟩. ⟨inserm-00559533⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UGA U823

264 View

502 Download